In the present review, we will concentrate on the role of a proliferation-inducing ligand (APRIL, TNFSF13), BAFF (TNFSF13B), and their receptors in cancer, the novel biological therapies targeting this system, their role in breast cancer, and their potential use as therapeutic targets. This evidence concerns the gene TNFSF13B and breast cancer.